SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001274173-24-000120
Filing Date
2024-11-14
Accepted
2024-11-14 12:39:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 JANUS AMENDMENT Tenax093024.txt SC 13G/A 11815
  Complete submission text file 0001274173-24-000120.txt   13937
Mailing Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517
Business Address 101 GLEN LENNOX DRIVE SUITE 300 CHAPEL HILL NC 27517 919-855-2100
TENAX THERAPEUTICS, INC. (Subject) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-58467 | Film No.: 241459500
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 201 BISHOPSGATE LONDON X0 EC2M 3AE
Business Address 201 BISHOPSGATE LONDON X0 EC2M 3AE 442078181818
JANUS HENDERSON GROUP PLC (Filed by) CIK: 0001274173 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Y9 | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice
(CF Office: 02 Finance)